STOCK TITAN

T2 Biosystems Stock Price, News & Analysis

TTOO OTC Link

Company Description

T2 Biosystems (OTC Link: TTOO) is a publicly traded diagnostics & research company in the Surgical & Medical Instruments & Apparatus sector. The company has a market capitalization of $2.4M, ranking #6,915 among all listed U.S. companies by market cap.

TTOO stock has declined 98.2% over the past year. Shares last traded at $0.0022.

On a trailing twelve-month basis, T2 Biosystems reported revenue of $7.2M with net income of -$50.1M and diluted earnings per share of $-19.19. The company operates at a net profit margin of -696.2%.

This page provides a comprehensive overview of TTOO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$0.0022
+340.00%
+0.00
Last updated: March 20, 2026 at 09:47
-98.24%
Performance 1 year

T2 Biosystems (TTOO) stock last traded at $0.0022, up 340.00% from the previous close. Over the past 12 months, the stock has lost 98.2%. At a market capitalization of $2.4M, TTOO is classified as a micro-cap stock with approximately 28.0M shares outstanding.

SEC Filings

T2 Biosystems has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on July 10, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TTOO SEC filings →

Financial Highlights

$7.2M
Revenue (TTM)
-$50.1M
Net Income (TTM)
-$48.1M
Operating Cash Flow

T2 Biosystems generated $7.2M in revenue over the trailing twelve months, operating income reached -$49.7M (-690.4% operating margin), and net income was -$50.1M, reflecting a -696.2% net profit margin. Diluted earnings per share stood at $-19.19. The company generated -$48.1M in operating cash flow. With a current ratio of 0.45, short-term liquidity bears monitoring.

Upcoming Events

Short Interest History

Last 12 Months

Short interest in T2 Biosystems (TTOO) currently stands at 4.9 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 52.3%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for T2 Biosystems (TTOO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

TTOO Company Profile & Sector Positioning

T2 Biosystems (TTOO) operates in the Diagnostics & Research industry within the broader Surgical & Medical Instruments & Apparatus sector and is listed on the OTC Link.

Investors comparing TTOO often look at related companies in the same sector, including Rushnet Inc (RSHN), Identa Ltd Rvice (IDTA), Interpace Biosciences Inc (IDXG), Invitro Internat (IVRO), and Angle Plc Surrey (ANPCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TTOO's relative position within its industry.

Frequently Asked Questions

What is the current stock price of T2 Biosystems (TTOO)?

The current stock price of T2 Biosystems (TTOO) is $0.0022 as of March 20, 2026.

What is the market cap of T2 Biosystems (TTOO)?

The market cap of T2 Biosystems (TTOO) is approximately 2.4M. Learn more about what market capitalization means .

What is the revenue (TTM) of T2 Biosystems (TTOO) stock?

The trailing twelve months (TTM) revenue of T2 Biosystems (TTOO) is $7.2M.

What is the net income of T2 Biosystems (TTOO)?

The trailing twelve months (TTM) net income of T2 Biosystems (TTOO) is -$50.1M.

What is the earnings per share (EPS) of T2 Biosystems (TTOO)?

The diluted earnings per share (EPS) of T2 Biosystems (TTOO) is $-19.19 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of T2 Biosystems (TTOO)?

The operating cash flow of T2 Biosystems (TTOO) is -$48.1M. Learn about cash flow.

What is the profit margin of T2 Biosystems (TTOO)?

The net profit margin of T2 Biosystems (TTOO) is -696.2%. Learn about profit margins.

What is the operating margin of T2 Biosystems (TTOO)?

The operating profit margin of T2 Biosystems (TTOO) is -690.4%. Learn about operating margins.

What is the current ratio of T2 Biosystems (TTOO)?

The current ratio of T2 Biosystems (TTOO) is 0.45, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of T2 Biosystems (TTOO)?

The operating income of T2 Biosystems (TTOO) is -$49.7M. Learn about operating income.